Education
About Us
Working with TipRanks
Follow Us
ARKK - ETF AI Analysis
Top Page
Ark Innovation Etf (ARKK)
Rating:59Neutral
Price Target:―
Positive Factors
Focused Innovation Theme
The fund targets innovative companies in areas like technology and health care, offering exposure to high-growth themes that many broad market funds miss.
Sector Diversification Within Growth Areas
Holdings are spread across several growth-oriented sectors such as health care, technology, consumer cyclical, and financials, which helps avoid relying on just one industry.
Large Asset Base
The ETF manages a sizable pool of assets, which can support trading liquidity and make it easier for investors to enter and exit positions.
Negative Factors
High Expense Ratio
The fund charges relatively high annual fees compared with many ETFs, which can eat into long-term returns.
Concentrated Top Holdings
A small number of stocks like Tesla and other large positions make up a significant share of the portfolio, increasing the impact if any of them perform poorly.
Recent Performance Weakness
The ETF has shown weak short-term performance, with several top holdings such as Tesla, Roku, Shopify, Robinhood, and Palantir lagging so far this year.
ARKK vs. SPDR S&P 500 ETF (SPY)
AUM6.09B
RegionGlobal
Expense Ratio0.75%
Beta2.00
IssuerARK
Inception DateOct 31, 2014
Dividend YieldN/A
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume12,001,237
30 Day Avg. Volume8,344,343
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
98.63Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering44
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ARKK Summary
ARKK is an exchange-traded fund that focuses on “disruptive innovation” rather than tracking a traditional index. It is actively managed and invests in U.S. companies working on new technologies in areas like artificial intelligence, robotics, genetics, and digital finance. Well-known holdings include Tesla and AMD, along with firms in biotech and online platforms. Someone might invest in ARKK if they want growth potential from cutting-edge tech and health care companies in a single, diversified fund. A key risk is that these innovative stocks can be very volatile, so the ETF’s price can rise and fall sharply.
How much will it cost me?The Ark Innovation ETF (ARKK) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed, meaning experts are constantly adjusting its holdings to focus on innovative and disruptive companies.
What would affect this ETF?The Ark Innovation ETF (ARKK) could benefit from continued advancements in technology and innovation, particularly in areas like artificial intelligence, robotics, and genomics, which are key focuses of its portfolio. However, it may face challenges from rising interest rates, which can negatively impact growth-focused investments, and regulatory changes in sectors like fintech or healthcare. Global economic uncertainty could also affect the performance of its top holdings, such as Tesla and Coinbase, which are sensitive to market conditions.
ARKK Top 10 Holdings
ARKK is leaning hard into U.S.-centric disruptive growth, with Tesla still the flagship but lately losing steam and acting more like an anchor than an engine. High-profile innovators like Shopify, Robinhood, and Palantir are also lagging, adding to the drag. On the brighter side, AMD has been a rare steady climber, and Beam Therapeutics is showing rising momentum, giving a lift from the health care and AI side. Overall, the fund is concentrated in tech, fintech, and genomics, making it a high-conviction bet on innovation with plenty of volatility baked in.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Tesla | 11.24% | $702.59M | $1.57T | 17.31% | 73 Outperform | |
| Crispr Therapeutics AG | 6.23% | $389.03M | $5.09B | 6.74% | 40 Underperform | |
| Tempus AI, Inc. Class A | 5.15% | $321.94M | $9.24B | -41.92% | 52 Neutral | |
| Roku | 4.80% | $299.80M | $13.31B | -9.09% | 65 Neutral | |
| Shopify | 4.28% | $267.36M | $147.10B | -12.19% | ― | |
| Robinhood | 4.15% | $259.19M | $68.17B | 16.38% | 68 Neutral | |
| Advanced Micro Devices | 3.96% | $247.64M | $338.02B | 83.31% | 73 Outperform | |
| Beam Therapeutics | 3.82% | $238.55M | $2.83B | -13.83% | 58 Neutral | |
| Coinbase Global | 3.69% | $230.80M | $43.39B | -40.10% | 68 Neutral | |
| Roblox | 3.50% | $218.62M | $44.77B | -5.36% | 51 Neutral |
ARKK Technical Analysis
Negative
―
Price Trends
78.51
Negative
81.24
Negative
75.00
Negative
Market Momentum
-2.80
Positive
38.63
Neutral
38.17
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For ARKK, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 75.20, equal to the 50-day MA of 78.51, and equal to the 200-day MA of 75.00, indicating a bearish trend. The MACD of -2.80 indicates Positive momentum. The RSI at 38.63 is Neutral, neither overbought nor oversold. The STOCH value of 38.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ARKK.
ARKK Peer Comparison
Comparison Results
Performance Comparison
ARKK
Ark Innovation Etf
70.25
3.77
5.67%
BAI
iShares A.I. Innovation and Tech Active ETF
―
―
―
ARKQ
ARK Autonomous Technology & Robotics ETF
―
―
―
ARKW
ARK Next Generation Internet ETF
―
―
―
FWD
AB Disruptors ETF
―
―
―
ARKG
ARK Genomic Revolution ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents